探索GLP-1RR偏差和平衡干结合中的 conformational 转换
Marc Xu1,2, Horst Vogel1,3,4, Shuguang Yuan1,5
1Research Center for Computer-Aided Drug Discovery, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
Molecules (Basel, Switzerland)
|August 14, 2025
概括
了解葡萄糖类-1受体 (GLP-1R) 激活动态是开发新代谢障碍药物的关键. 分子动力学模拟揭示了不同的激动剂,如小分子和,如何独特地激活GLP-1R信号通路.
科学领域:
- 生物化学和结构生物学.
- 药理学 药理学是指药理学的学科.
- 分子建模分子建模
背景情况:
- 葡萄糖类-1受体 (GLP-1R) 是B1类G蛋白合受体 (GPCR),是2型糖尿病和肥胖等代谢障碍的关键治疗标.
- 基于GLP-1R的疗法由于开发了多种功能性激动剂和巨大的市场潜力,正在获得显著的关注.
研究的目的:
- 研究GLP-1R与各种功能性激动剂复合的结构动态.
- 阐明不同的连接物诱导不同的信号通路偏好的原子层次机制.
主要方法:
- 用全原子分子动力学 (MD) 模拟来研究受体-连接体相互作用.
- 分析的重点是形状变化,结合模式,以及在激素结合时诱导的螺旋包装.
主要成果:
- 对于不同的激动剂 (CHU-128,danuglipron,19),观察到不同的结合模式和独特的螺旋包装.
- MD模拟揭示了特定的原子特征,解释了这些配体如何差异调节GLP-1R信号通路.
- 干特异性构造动力学与信号通路偏差有关.
结论:
- 该研究提供了对GLP-1R激活由各种激动剂的机制性见解.
- 研究结果支持合理设计下一代GLP-1R疗法,提高对代谢疾病的疗效和特异性.
相关概念视频
The Two-State Receptor Model
2.4K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.4K
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
Cooperative Allosteric Transitions
8.0K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.0K
Glucagon-like Receptor Agonists
418
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
418
GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
Ligand Binding Sites
13.2K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.2K


